Remove BioTech Remove Health Policy Remove Life Science Remove Study
article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech 270
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

IQVIA’s national prescription data revealed that prescriptions for mental health drugs grew 8% since 2019 — with a 33% rise among girls under 19. There is another data point in the study on women’s health and prescriptions — for ADHD drugs.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

84% of Americans told the Foundation that they were concerned about how much health care costs will affect them in the future, with 42% of patients saying they couldn’t afford to pay over $500 for an unexpected medical bill. Hospital costs contribute to rising medical costs to 49% of health consumers. Exacerbating U.S.

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

The study was written up by Beth Snyder Bulik in FiercePharma. Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Among the top 20 in this study were two pharma brands — Pfizer and AstraZeneca.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

By demographics, more women than men are concerned about rising costs for the three health care spending categories the survey studied: drug prices, insurance premiums, and healthcare costs (medical care services spending). A majority of people across political party share this concern: overall, 88% of U.S. 84% of Republicans.

BioTech 191
article thumbnail

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

Health Populi

Health Populi’s Hot Points: The last chart from the study (Figure 8) underscores the universality of the finding that lowering the price of prescription drugs is one of the very few issues in the U.S. 65% of Independents and. 57% of Republicans. that bring voters together.

Medicare 170